Looking to publish in ACS Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowACS Infectious Diseases highlights the role of chemistry in the multidisciplinary and collaborative field of infectious diseases.
Looking to publish in ACS Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
ACS Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.
Article
Letter
Review
Perspective
Viewpoint
Recent Publications
Legionella pneumophila Encodes a Peptidoglycan Recycling Machinery Critical for Survival within Macrophages
Sushanta Ratna, Aastha Acharya, Miranda E. Roland, Marina P. Vasconcelos, Bella R. Carnahan, Alex Wang, Arit Ghosh, Abigail Bolt, Jacob Ellis, Stephen N. Hyland, Ashlyn S. Hillman, Joseph M. Fox, April M. Kloxin, M. Ramona Neunuebel, Catherine Leimkuhler Grimes
A Dibenzo- p -dioxin-Shaped New Chemotype of Glycopeptide Antibiotic Active against Drug-Resistant Pathogens
Xingkun Li, Mengru Wang, Lixin Yin, Jiawei Cao, Rui Wang, Xinzhu Wang, Qian Chen, Dexi Bi, Zhilong Zhao, Zixin Deng, Anwei Hou, Min Xu
Design, Synthesis, and Evaluation of Novel Thiazole-Based Peptidomimetic Compounds as Potent SARS-CoV-2 Main Protease Covalent Inhibitors
Weile Yin, Wai-Po Kong, Siu-Lun Leung, Zhiguang Liang, Yu Wai Chen, Kwok-Yin Wong
A Divergent MBL-Fold Metallo-Hydrolase (Kmh-1) from Klebsiella pneumoniae Confers Aztreonam Degradation and Expands the β-Lactamase Landscape
Jyoti Barman, Partho Biswas, Partha Roy, Saugata Hazra
Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against Mycobacterium tuberculosis
Claire Naylor, Gareth Prosser, Tracy Bayliss, Lila F. Berle, Joshua B. Wallach, Heather Kim, Rodrigo Aguilera Olvera, Stephen Thompson, Thomas R. Ioerger, Laura Simpson, Ruth Casanueva, Laura Guijarro-Lopez, Kevin D. Read, Paul G. Wyatt, Dirk Schnappinger, Clifton E. Barry, Simon R. Green, Helena I. M. Boshoff, Laura A. T. Cleghorn
Frequently asked questions
How long does it take to publish?
Median time to first peer review decision is 36.5 days, median time to acceptance is 92.2 days, and median time from acceptance to ASAP publication is 12.6 days.
Reformat to ACS Infectious Diseases using Livewrite PremiumIs a cover letter required?
A cover letter is required for every manuscript submission and must include the manuscript title, full author information, a summary of novelty and significance, justification of suitability for ACS Infectious Diseases, disclosure of any prior discussions with an editor, information on preprint use and updates, and a brief lay summary of approximately 150 words.
Reformat to ACS Infectious Diseases using Livewrite PremiumWhat are the publication costs?
Research articles can be published open access in this hybrid journal under CC BY or CC BY-NC-ND licenses, with pricing provided through ACS open access options and institutional read-and-publish agreements.
Reformat to ACS Infectious Diseases using Livewrite Premium